Nautilus Biotechnology, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2020 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Nautilus Biotechnology, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2020 to Q4 2024.
  • Nautilus Biotechnology, Inc. Operating Lease, Right-of-Use Asset for the quarter ending December 31, 2024 was $28.3M, a 13.4% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2024 $28.3M -$4.38M -13.4% Dec 31, 2024 10-K 2025-02-27
Q3 2024 $29.4M -$4.29M -12.7% Sep 30, 2024 10-Q 2024-10-29
Q2 2024 $30.5M -$4.21M -12.1% Jun 30, 2024 10-Q 2024-07-30
Q1 2024 $31.6M -$4.14M -11.6% Mar 31, 2024 10-Q 2024-04-30
Q4 2023 $32.6M +$3.77M +13.1% Dec 31, 2023 10-K 2025-02-27
Q3 2023 $33.7M +$5.92M +21.3% Sep 30, 2023 10-Q 2023-10-31
Q2 2023 $34.7M +$6.38M +22.5% Jun 30, 2023 10-Q 2023-08-02
Q1 2023 $35.7M +$6.85M +23.7% Mar 31, 2023 10-Q 2023-05-02
Q4 2022 $28.9M -$511K -1.74% Dec 31, 2022 10-K 2024-02-28
Q3 2022 $27.8M +$24.1M +653% Sep 30, 2022 10-Q 2022-11-01
Q2 2022 $28.3M +$27.5M +3318% Jun 30, 2022 10-Q 2022-08-02
Q1 2022 $28.9M Mar 31, 2022 10-Q 2022-05-03
Q4 2021 $29.4M +$24.5M +507% Dec 31, 2021 10-K 2023-02-23
Q3 2021 $3.69M Sep 30, 2021 10-Q 2021-11-02
Q2 2021 $828K Jun 30, 2021 10-Q 2021-08-10
Q4 2020 $4.84M Dec 31, 2020 10-K 2022-02-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.